Transfer of the patient to a new type of insulin or another manufacturer's insulin should be carried out under strict medical supervision, since a change in dosage may be required due to a change in the concentration of insulin, a brand (manufacturer), type of insulin (soluble, insulin-isophane, etc.) insulin (animal origin) and / or mode of production.In addition, correction of concomitant oral hypoglycemic therapy may be required. The use of inadequate insulin doses or discontinuation of treatment, especially in patients with type 1 diabetes, can lead to the development of hyperglycemia and diabetic ketoacidosis - conditions that are potentially life threatening.
Hypoglycaemia
The time through which hypoglycemia develops depends on the rate of onset of the effect of the insulin used and, in this connection, can change with a change in the treatment regimen. Conditions that can change or make less pronounced precursors of hypoglycaemia include: the long existence of diabetes, the intensification of insulin therapy, the presence of diabetic neuropathy, the use of certain medications such as beta-blockers, or the transfer of a patient from animal insulin to human insulin.
Correction of insulin doses may also be required if patients increase physical activity or change their usual eating patterns. Physical exercise performed immediately after a meal can increase the risk of developing hypoglycemia.Compared to soluble human insulin, hypoglycemia may develop earlier after the injection of fast acting insulin analogues.
Uncompensated hypoglycemic or hyperglycaemic reactions can lead to loss of consciousness, coma development or death.
The need for insulin can change with diseases or emotional overload.
Instructions for use and handling of a pre-filled syringe pen SoloStar®
Before the first use, the syringe pen should be held at room temperature for 1-2 hours.
Before use, inspect the cartridge inside the syringe pen. It should only be used if the solution is clear, colorless, contains no visible solid particles and resembles water in a consistency.
Empty SoloStar® pen need not be reused and must be destroyed.
To prevent infection, a pre-filled syringe pen should only be used by one patient and not transferred to another person.
Handling of the SoloStar® syringe handle
Carefully read the usage information before using the SoloStar® pen.
Important information on using the syringe pen SoloStar®
Before each use, use caution connect a new needle to the syringe pen and conduct a safety test. Use only needles that are compatible with the SoloStar® syringe handle.
It is necessary to take special precautions to avoid accidents involving the use of a needle and the possibility of infection transmission.
Do not use the SoloStar® pen if it is damaged or if you are not sure that it will work properly.
Always have a spare SoloStar® pen in case you lose or damage your a copy of the SoloStar® pen.
Storage Instruction
Please read the "Storage conditions" section for the storage rules for the SoloStar® pen.
If the SoloStar® pen is stored in the refrigerator, remove it from there 1-2 hours before the proposed injection so that the solution will take up room temperature. The introduction of chilled insulin is more painful.
Used syringe pen SoloStar® must be destroyed.
Caring for the syringe handle SoloStar®
The SoloStar® syringe handle must be protected from dust and dirt. The outer side of the SoloStar® pen can be cleaned by wiping it with a damp cloth.
Do not immerse in liquid, do not rinse or lubricate the SoloStar® syringe, as this can damage it.
Syringe handle SoloStar® precisely doses insulin and is safe in work. It also requires careful handling. Avoid situations in which the SoloStar® pen can be damaged. If you suspect that your copy of the SoloStar® pen can be damaged, use a new syringe pen.
Stage 1. Insulin control
It is necessary to check the label on the SoloStar® syringe pen to ensure that it contains the appropriate insulin. For the preparation of Apidra®, the SoloStar® syringe pen is blue with a dark blue button with a relief ring for injection. After removing the cap of the syringe-pen, monitor the appearance of the insulin contained in it: the insulin solution must be transparent, colorless, free of visible solid particles and resemble water in a consistency.
Stage 2. Connecting the needle
Use only needles that are compatible with the SoloStar® syringe handle.
For each subsequent injection, a new sterile needle. After removing the cap, the needle should be carefully installed on the syringe pen.
Step 3. Performing a safety test
Before each injection, a safety test must be carried out and make sure that the syringe pen and needle work well and air bubbles are removed.
Measure the dose equal to 2 units. The outer and inner needle caps must be removed.
With the needle pen up, gently tap the cartridge with the insulin finger so that all air bubbles are directed toward the needle. Fully press the injection injection button.
If insulin appears at the tip of the needle, it means that the pen and needle work correctly.
If no insulin appears on the tip of the needle, stage 3 can be repeated until insulin appears on the tip of the needle.
Stage 4. Dose selection
The dose can be set to an accuracy of 1 unit from a minimum dose of 1 unit to a maximum dose of 80 units. If you need to enter a dose, exceeding 80 units, two or more injections should be given.The dosage window should indicate "0" after the completion of the safety test. After this, the required dose can be set.
Stage 5. Dosing Introduction
The patient should be informed about the technology injection by a medical professional.
The needle must be inserted under the skin. The injection button must be pressed completely. It is held in this position for another 10 seconds until the needle is removed. Thus, the introduction of the selected of the insulin dose completely.
Stage 6. Extraction and ejection of a needle
In all cases, the needle after each injection should be removed and discarded. This ensures the prevention of contamination and / or infection, air entering the insulin tank and leakage of insulin.
When removing and ejecting a needle, special precautions. Observe the recommended safety measures for removing and disposing of needles (for example, the technique of putting the cap on with one hand) in order to reduce the risk of accidents involving the use of the needle, and to prevent infection.
After removing the needle, close the SoloStar® penwith a lintel.